Chimerix Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow JonesDec 30, 2024 10:45 ET · Ratings

JonesTrading Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsDec 30, 2024 09:31 ET · Ratings

Chimerix Announces NDA Submission For Dordaviprone - Quick Facts

RTTNewsDec 30, 2024 07:28 ET

Chimerix Seeks Accelerated FDA Approval for Experimental Tumor Drug

MT NewswiresDec 30, 2024 07:26 ET

Express News | Chimerix Inc - Enters Credit Facility of up to $30 Million With Svb

ReutersDec 30, 2024 07:04 ET

Chimerix Seeks FDA Approval for New Drug Targeting Deadly Brain Cancer

BenzingaDec 30, 2024 07:01 ET